CLINICAL_TRIALS
trial_result
· 2014-02-10
Clinical Trial Update: Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda [Phase 3]
Summary
This update reports the completion and posted results of a Phase 3 pilot trial evaluating deferasirox for treating porphyria cutanea tarda.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Texas Southwestern Medical Center | Conditions: Porphyria Cutanea Tarda | Phase 3 | Status: COMPLETED | Results posted: 2014-02-10